Delivery Order SPE2DB20D1100-SPE2DB24FC3K4

Award Date 6/18/24
Potential Completion Date 7/11/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Envarsus XR 1 mg tablets, a pharmaceutical product, to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the Department of Defense (DoD), with a ceiling value of $1,465.68. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Envarsus XR 0.75 mg tablets over a period ending on October 9, 2024. The contract has a ceiling value of $1,103.64 and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Envarsus XR 4 mg tablets. The $1,615.33 firm fixed-price delivery order has an ultimate completion date of October 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Envarsus XR 1 mg tablet in quantities of 30. The $1,465.68 ceiling value Firm Fixed Price contract was awarded on June 11, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of July 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of the pharmaceutical product Envarsus XR 1 mg tablet to the U.S. government. The $1,465.68 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of May 6, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to federal agencies, particularly the Department of Defense (DoD) and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Envarsus XR 4 mg tablets, a pharmaceutical product. The award, with a ceiling value of $19,383.96, was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 through December 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of Envarsus XR 1 mg tablets. The contract, valued at $1,216.11, is a firm fixed-price delivery order with a period of performance through July 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of the pharmaceutical product Envarsus XR 1 mg tablet, with a ceiling value of $1,099.26. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense, and has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Envarsus XR 1 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price and a ceiling value of $1,621.48. It has an ultimate completion date of July 31, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,621.48 firm fixed-price delivery order is for the provision of Envarsus XR 1 mg tablets, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC3K4
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Envarsus XR 4 mg tablets in quantities of 100, with a ceiling value of $1,615.33 and a completion date of July 11, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation.

Amerisourcebergen is a major pharmaceutical distribution company that has been awarded several federal contracts to provide a wide range of prescription medications, over-the-counter drugs, and medical supplies to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). This specific order is part of a larger single-award IDC valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide.

Generated 9/17/24, 10:23 AM